167 related articles for article (PubMed ID: 2022970)
1. Determination of proliferative activities in human brain tumor specimens: a comparison of three methods.
Morimura T; Kitz K; Stein H; Budka H
J Neurooncol; 1991 Feb; 10(1):1-11. PubMed ID: 2022970
[TBL] [Abstract][Full Text] [Related]
2. In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67.
Morimura T; Kitz K; Budka H
Acta Neuropathol; 1989; 77(3):276-82. PubMed ID: 2922990
[TBL] [Abstract][Full Text] [Related]
3. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.
Onda K; Davis RL; Shibuya M; Wilson CB; Hoshino T
Cancer; 1994 Oct; 74(7):1921-6. PubMed ID: 7521787
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical evaluation of proliferative activity in human brain tumours.
Girino M; Riccardi A; Danova M; Gaetani P; Butti G; Giordano M; Cuomo A
Anal Cell Pathol; 1990 Sep; 2(5):269-75. PubMed ID: 2275874
[TBL] [Abstract][Full Text] [Related]
5. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens.
Khoshyomn S; Maier H; Morimura T; Kitz K; Budka H
Acta Neuropathol; 1993; 86(6):582-9. PubMed ID: 7906072
[TBL] [Abstract][Full Text] [Related]
6. The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time.
Schröder R; Bien K; Kott R; Meyers I; Vössing R
Acta Neuropathol; 1991; 82(5):389-94. PubMed ID: 1767633
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of proliferative cells.
Mokrý J; Nĕmecek S
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626
[TBL] [Abstract][Full Text] [Related]
8. Proliferative potential of brain tumors. Analyses with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nuclear organizer region counts.
Shibuya M; Ito S; Miwa T; Davis RL; Wilson CB; Hoshino T
Cancer; 1993 Jan; 71(1):199-206. PubMed ID: 8416716
[TBL] [Abstract][Full Text] [Related]
9. Comparison of brain tumor growth kinetics by proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine (BrdU) labeling.
Lee KS; Yang WI
Yonsei Med J; 1992 Sep; 33(3):265-71. PubMed ID: 1363339
[TBL] [Abstract][Full Text] [Related]
10. Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.
Cher ML; Chew K; Rosenau W; Carroll PR
Prostate; 1995 Feb; 26(2):87-93. PubMed ID: 7855002
[TBL] [Abstract][Full Text] [Related]
11. A correlative study of in vivo and in vitro labeling index using bromodeoxyuridine in human brain tumors.
Kharbanda K; Dinda AK; Sarkar C; Karak AK; Dhir R; Mathur M; Roy S
J Neurooncol; 1995; 23(3):185-90. PubMed ID: 7673980
[TBL] [Abstract][Full Text] [Related]
12. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine].
Okuda Y; Taomoto K; Saya H; Ijichi A; Kudo H; Kokunai T; Tamaki N; Matsumoto S
No To Shinkei; 1989 Apr; 41(4):383-90. PubMed ID: 2765301
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
Ghazvini S; Kroll S; Char DH; Frigillana H
Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099
[TBL] [Abstract][Full Text] [Related]
14. Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections.
Sasaki A; Naganuma H; Kimura R; Isoe S; Nakano S; Nukui H; Suzuki K; Kawaoi A
Acta Neurochir (Wien); 1992; 117(3-4):178-81. PubMed ID: 1357920
[TBL] [Abstract][Full Text] [Related]
15. The proliferative potential of human ependymomas measured by in situ bromodeoxyuridine labeling.
Nagashima T; Hoshino T; Cho KG; Edwards MS; Hudgins RJ; Davis RL
Cancer; 1988 Jun; 61(12):2433-8. PubMed ID: 3284636
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) immunohistochemistry and in situ hybridization for histone mRNA.
Muskhelishvili L; Latendresse JR; Kodell RL; Henderson EB
J Histochem Cytochem; 2003 Dec; 51(12):1681-8. PubMed ID: 14623936
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of cell growth fraction in formalin-fixed and paraffin-embedded murine tissue.
Birner P; Ritzi M; Musahl C; Knippers R; Gerdes J; Voigtländer T; Budka H; Hainfellner JA
Am J Pathol; 2001 Jun; 158(6):1991-6. PubMed ID: 11395376
[TBL] [Abstract][Full Text] [Related]
18. Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer.
Thor AD; Liu S; Moore DH; Edgerton SM
J Clin Oncol; 1999 Feb; 17(2):470-7. PubMed ID: 10080587
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical approach to reveal the growth potential of uterine cancers using anti-BrdU antibody and Ki-67].
Yoshinouchi M
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2513-21. PubMed ID: 2614188
[TBL] [Abstract][Full Text] [Related]
20. Cell-cycle analysis detecting endogenous nuclear antigens: comparison with BrdU-in vivo labeling and an application to lung tumors.
Hayashi Y; Fukayama M; Koike M; Kaseda S; Ikeda T; Yokoyama T
Acta Pathol Jpn; 1993 Jun; 43(6):313-9. PubMed ID: 8346708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]